Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("National cancer inst")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 86

  • Page / 4
Export

Selection :

  • and

Methods and strategies in lung cancer controlCASTONGUAY, A.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2641s-2651s, issn 0008-5472Conference Paper

Laboratory of tumor cell biology. Annual meetingAIDS research and human retroviruses. 1994, Vol 10, pp S1-S170, issn 0889-2229, SUP3Conference Proceedings

Investigational strategies for detection and intervention in early lung cancerCancer research (Baltimore). 1992, Vol 52, Num 9, issn 0008-5472Conference Proceedings

Future studies in localized prostate cancer. That should we think ? What can we do ?LANGE, P. H.The Journal of urology. 1994, Vol 152, Num 5, pp 1932-1938, issn 0022-5347, 2Conference Paper

Problems and perspectives on the use of decision-analysis models for prostate cancerSIMPSON, K. N.The Journal of urology. 1994, Vol 152, Num 5, pp 1888-1893, issn 0022-5347, 2Conference Paper

Prostate cancer, screening and the generalist physicianROBERTS, R. G.The Journal of urology. 1994, Vol 152, Num 5, pp 1693-1694, issn 0022-5347, 2Conference Paper

Public health perspective : the health policy implications of screening for prostate cancerWOOLF, S. H.The Journal of urology. 1994, Vol 152, Num 5, pp 1685-1688, issn 0022-5347, 2Conference Paper

The role of watchful waiting in the management of localized prostate cancerCHODAK, G. W.The Journal of urology. 1994, Vol 152, Num 5, pp 1766-1768, issn 0022-5347, 2Conference Paper

Impact of radical prostatectomy in the management of clinically localized diseasePAULSON, D. F.The Journal of urology. 1994, Vol 152, Num 5, pp 1826-1830, issn 0022-5347, 2Conference Paper

Expectant management of early stage prostatic cancer : swedish experienceJOHANSSON, J.-E.The Journal of urology. 1994, Vol 152, Num 5, pp 1753-1756, issn 0022-5347, 2Conference Paper

Measuring health related quality of life in men with prostate cancerLITWIN, M. S.The Journal of urology. 1994, Vol 152, Num 5, pp 1882-1887, issn 0022-5347, 2Conference Paper

Prostate cancer : a patient's perspectiveHOWE, R. J.The Journal of urology. 1994, Vol 152, Num 5, pp 1700-1703, issn 0022-5347, 2Conference Paper

Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapyZAGARS, G. K.The Journal of urology. 1994, Vol 152, Num 5, pp 1786-1791, issn 0022-5347, 2Conference Paper

Nitrosamine-induced lung carcinogenesis and Ca2+/calmodulin antagonistsSCHÜLLER, H. M.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2723s-2726s, issn 0008-5472Conference Paper

The clinical evaluation of cancer chemoprevention agents : defining fand contrasting phase I, II, and III objectivesGOODMAN, G. E.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2752s-2757s, issn 0008-5472Conference Paper

Natural hisory of changes in prostate specific antigen in early stage prostate cancerPEARSON, J. D; CARTER, H. B.The Journal of urology. 1994, Vol 152, Num 5, pp 1743-1748, issn 0022-5347, 2Conference Paper

The use of prostate specific antigen for prostate cancer screening : a managed care perspectiveHANDLEY, M. R; STUART, M. E.The Journal of urology. 1994, Vol 152, Num 5, pp 1689-1692, issn 0022-5347, 2Conference Paper

Amplification and expression of the bcl-1 gene in human solid tumor cell linesFAUST, J. B; MEEKER, T. C.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2460-2463, issn 0008-5472Conference Paper

Clinical significance of ras oncogene activation in human lung cancerRODENHUIS, S; SLEBOS, R. J. C.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2665s-2669s, issn 0008-5472Conference Paper

Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cellsTOTPAL, K; AGARWA, S; AGGARWAL, B. B et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2557-2562, issn 0008-5472Conference Paper

Tumor cell kinetics following antineoplastic ether phospholipid treatmentPRINCIPE, P; SIDOTI, C; BRAQUET, P et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2509-2515, issn 0008-5472Conference Paper

Detection and treatment of prostate cancer : perspective of the urologistOLSSON, C. A; GOLUBOFF, E. T.The Journal of urology. 1994, Vol 152, Num 5, pp 1695-1699, issn 0022-5347, 2Conference Paper

Expectant management of clinically localized prostatic cancerWARNER, J; WHITMORE, W. F.The Journal of urology. 1994, Vol 152, Num 5, pp 1761-1765, issn 0022-5347, 2Conference Paper

Application of molecular genetics to the early diagnosis and screeting of lung cancerBIRRER, M. J; BROWN, P. H.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2658s-2664s, issn 0008-5472Conference Paper

Growth of small cell lung cancer cells : stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivoSETHI, T; LANGDON, S; SMYTH, J et al.Cancer research (Baltimore). 1992, Vol 52, Num 9, pp 2737s-2742s, issn 0008-5472Conference Paper

  • Page / 4